Downregulated expression of PBRM1 in sarcomatoid hepatocellular carcinoma-Reference-Cited by-同舟云学术

Downregulated expression of PBRM1 in sarcomatoid hepatocellular carcinoma

Published:2024-01-26 Issue:3 Volume:27 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Yoshida Terufumi¹,Sakai Kazuko²,Kaibori Masaki¹,Ishida Mitsuaki³,Tanaka Shogo⁴,Kubo Shoji⁴,Nakai Takuya⁵,De Velasco Marco²,Matsushima Hideyuki¹,Tsuta Koji⁶,Sekimoto Mitsugu¹,Nishio Kazuto²

Affiliation:

1. Department of Surgery, Kansai Medical University, Hirakata, Osaka 573‑1010, Japan

2. Department of Genome Biology, Kindai University Faculty of Medicine, Osakasayama, Osaka 589‑8511, Japan

3. Department of Pathology, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka 569‑8686, Japan

4. Department of Hepato‑Biliary‑Pancreatic Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Osaka 545‑8585, Japan

5. Department of Surgery, Kindai University Faculty of Medicine, Osakasayama, Osaka 589‑8511, Japan

6. Department of Pathology, Kansai Medical University, Hirakata, Osaka 573‑1010, Japan

Publisher

Spandidos Publications

Reference34 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis;Roberts;Hepatology,2018

3. Morphologic subtypes of hepatocellular carcinoma;Torbenson;Gastroenterol Clin North Am,2017

4. Sarcomatoid hepatocellular carcinoma with spontaneous intraperitoneal bleeding;Watanabe;Intern Med,2015

5. Sarcomatoid hepatocellular carcinoma versus conventional hepatocellular carcinoma: A systematic review and meta-analysis;Lv;J Cancer Res Clin Oncol,2022